The present study demonstrated that B3GNT3 is an oncogene in early-stage cervical cancer and further exploration of the mechanism by which B3GNT3 is involved in the progression and LNM of cervical cancer is required. This evidence concerns the gene B3GNT3 and cervical cancer.